Medtronic, Inc. announced the successful implant of its Cardioblate Closure Left Atrial Appendage Occlusion Device as part of a U.S. clinical trial.
Products
Disc Motion Technologies Announces the First Surgical Procedure Using Inlign Multi-Level Hybrid System
Disc Motion Technologies announced today that the implantation of the Inlign™ MLH system, the World’s first posteriorly implanted multi-level hybrid system was successfully implanted in a 67 year old patient.
AxioMed Spine Corporation Receives CE Mark For Freedom Lumbar Disc
AxioMed® Spine Corporation announces the receipt of CE Mark approval for its Freedom® Lumbar Disc, an elastomeric total spinal disc replacement device.
FDA to Review Its Approval of Knee Device
The Food and Drug Administration said it will re-examine its decision to approve a knee-surgery device last December over the objections of several scientists and managers at the agency, according to a letter from the FDA that the Senate Finance Committee reviewed Monday.
St. Jude Medical Announces European Approval of Its Newest and Most Efficient Heart Failure Devices
St. Jude Medical, Inc. today announced European CE Mark approval of its Promote Accel™ implantable cardiac resynchronization therapy defibrillator (CRT-D).
Stryker Corp. receives subpoena in New Jersey probe of medical device makers
Stryker Corp. has received a subpoena from the Attorney General of New Jersey related to an investigation of financial relationships between companies that make medical products and surgeons that use them.
Article Reports Fewer Repeat Procedures With Boston Scientific’s TAXUS® Liberte® Stent
Journal of American College of Cardiology reports fewer repeat procedures with Boston Scientific’s TAXUS® Liberte® Paclitaxel-Eluting Stent compared to patients treated with ‘olimus-based drug-eluting stents.
St. Jude Medical Announces FDA Approval of Current Plus ICD and Promote Plus CRT-D Devices
St. Jude Medical, Inc. today announced U.S. Food and Drug Administration approval of the Promote® Plus cardiac resynchronization therapy defibrillator and Current® Plus implantable cardioverter defibrillators.
Covidien Announces Definitive Agreement to Acquire VNUS Medical Technologies, Inc.
Covidien and VNUS Medical Technologies, Inc. today announced that Covidien has reached a definitive agreement to acquire VNUS, a developer of medical devices for minimally invasive treatment of venous reflux disease.
Edwards Lifesciences Receives FDA Approval for New Heart Valve
Edwards Lifesciences Corporation, the world leader in the science of heart valves, today announced that it has received approval from the U.S. Food and Drug Administration for the Carpentier-Edwards PERIMOUNT Magna Ease aortic valve, designed for easier implantation in the heart.
New Study Shows that Zilver PTX from Cook Medical Effectively Treats Blockages in Critical Thigh Artery
Preliminary data presented today at the 32nd annual SCAI Scientific Sessions show that 82 percent of patients treated with Cook Medical’s Zilver® PTX™ drug-eluting peripheral stent were free from reintervention at two-year follow up.
CONMED Announces Full Market Release of the Paladin™ Suture Anchor for Rotator Cuff Repair
CONMED Corporation’s CONMED Linvatec arthroscopy unit announced today the full market release of the Paladin™ Rotator Cuff Suture Anchor System following its preview at the recent Spring Arthroscopy Association of North America Annual Meeting.
Sadra Medical Raises $30 Million
Sadra Medical today announced it has raised $30 million in new investment capital.
Gore Receives FDA Clearance For GORE BIO-A Fistula Plug
W. L. Gore & Associates announced that the US Food and Drug Administration has given the company 510(k) clearance to market the GORE BIO-A Fistula Plug, the next generation of anal fistula repair.
Medtronic Introduces The Vertex Select™ Reconstruction System Occipitocervical Module
Medtronic, Inc. announced the U.S. launch of the VERTEX SELECT™ Reconstruction System Occipitocervical Module.
Endosense Receives CE Mark for TactiCath Force-Sensing Ablation Catheter
Endosense, a medical technology company focused on enabling the broad adoption of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received the CE mark for its TactiCath system.